The second COVID-19 emergency status declaration for Japan: effects as of February 7, 2021
Junko Kurita, Tamie Sugawara, Yasushi Ohkusa
doi: https://doi.org/10.1101/2020.12.29.20248977
Junko Kurita
1Department of Nursing, Tokiwa University, Ibaraki, Japan
Tamie Sugawara
2National Institute of Infectious Diseases, Tokyo, Japan
Yasushi Ohkusa
2National Institute of Infectious Diseases, Tokyo, Japan
Article usage
Posted March 12, 2021.
The second COVID-19 emergency status declaration for Japan: effects as of February 7, 2021
Junko Kurita, Tamie Sugawara, Yasushi Ohkusa
medRxiv 2020.12.29.20248977; doi: https://doi.org/10.1101/2020.12.29.20248977
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (203)
- Cardiovascular Medicine (2955)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12768)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4602)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2935)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (927)
- Medical Education (428)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4379)
- Nursing (237)
- Nutrition (640)
- Oncology (2280)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1198)
- Primary Care Research (499)
- Public and Global Health (6967)
- Radiology and Imaging (1536)
- Respiratory Medicine (916)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)